PharmaShots | Incisive News in 3 Shots

Subscribe Now

organon

Organon and Shanghai Henlius Biotech Provides Update on P-III Trial of HLX11 (Biosimilar, Perjeta)

Organon and Shanghai Henlius Biotech Provides Update on P-III Trial of HLX11 (Biosimilar, Perjeta)

September 30, 2024

Organon to Acquire Dermavant for an Aggregate of ~$1.2B

Organon to Acquire Dermavant for an Aggregate of ~$1.2B

September 18, 2024

Organon and Samsung Bioepis Launch Hadlima (biosimilar, adalimumab)

Organon and Samsung Bioepis Launch Hadlima (biosimilar, adalimumab)

July 3, 2023

Organon Launches Ontruzant (biosimilar, trastuzumab) for the Treatment of Gastric Cancer

Organon Launches Ontruzant (biosimilar, trastuzumab) for the Treatment of Gastric Cancer

November 14, 2022

Organon Entered into a Research Collaboration and Exclusive License Agreement with Cirqle Biomedical for Non-hormonal Contraceptive Therapy

Organon Entered into a Research Collaboration and Exclusive License Agreement with Cirqle Biomedical for Non-hormonal Contraceptiv...

July 28, 2022

Organon Entered into an Agreement with Henlius to Commercialize Perjeta (pertuzumab) and Prolia/Xgeva (denosumab) Biosimilars

Organon Entered into an Agreement with Henlius to Commercialize Perjeta (pertuzumab) and Prolia/Xgeva (denosumab) Biosimilars

June 14, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us